Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant effects » significant effect (Expand Search), significantly affected (Expand Search)
significant event » significant effect (Expand Search), significant level (Expand Search), significant amount (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant effects » significant effect (Expand Search), significantly affected (Expand Search)
significant event » significant effect (Expand Search), significant level (Expand Search), significant amount (Expand Search)
-
441
-
442
Effect of busulfan treatment on vimentin, a supporting cytoskeletal protein.
Published 2025Subjects: -
443
Effects of busulfan treatment on the ultrastructure of the blood-testis barrier (BTB).
Published 2025Subjects: -
444
-
445
-
446
-
447
-
448
-
449
-
450
Mean 0-30 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
451
-
452
Mean 0-20 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
453
Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
Published 2025Subjects: -
454
Normalized significant family changes in abundance.
Published 2025“…<p>A) <i>Erysipelotrichaceae</i> significantly increased with CCE treatment; B) <i>Bacteroidales_unclassified</i> significantly decreased with CCE treatment; C) <i>Desulfovibrionaceae</i> significantly decreased with CCE treatment; D) <i>Rikenellaceae</i> significantly decreased with CCE treatment; E) <i>Coriobacteriaceae</i> significantly decreased with CCE treatment; F) <i>Erysipelotrichaceae</i> significantly increased with TRE treatment.…”
-
455
-
456
-
457
-
458
-
459
Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events.
Published 2024Subjects: “…adverse cardiovascular events…”
-
460